Background The Physiological and Operative Severity Score for the enUmeration of Mortality andmorbidity (POSSUM) and later modifications (P-POSSUM y CR-POSSUM) have been used to predictmorbidity and mortality rates among patients with rectal cancer undergoing surgery. These calculations needsome adjustment, however. The aim of this study was to assess the applicability of POSSUM to a group ofpatients with rectal cancer undergoing surgery, analysing surgical morbidity by means of several variables. Methods between January 1995 and December 2004, 273 consecutive patients underwent surgery forrectal cancer. Information was gathered about the patients, tumour and therapy. To assess the predictioncapacity of POSSUM, subgroups for analysis were created according to variables related to operativemorbidity and mortality. Results The global morbidity rate was 23.6% (31.2% predicted by POSSUM). The mortality rate was 0.7% (6.64, 1.95 and 2.08 predicted by POSSUM, P-POSSUM and CR-POSSUM respectively). POSSUMpredictions may be more accurate for patients younger than 51 years, older than 70 years, with low anaesthetic risk (ASA I/II), DUKES stage C and D, surgery duration of less than 180 minutes and for thosereceiving neoadjuvant therapy. Conclusion POSSUM is a good instrument to make results between different institutions and publicationcomparable. We found prediction errors for some variables related to
Introduction
Surgical evaluation processes are well-known medical procedures that help us detect and correct errors, as well as reinforce correct decisions taken about surgery. Surgical scoring systems must be capable of predicting morbidity and mortality and be fast, user friendly and applicable to a wide spectrum of situations. The Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) scoring system has been used to assess the quality of surgical results so as to estimate the probability of morbidity and mortality of patients according to their preoperative physiological status and the magnitude of surgery. Thus the POSSUM scoring system offers a way of comparing the results of surgical procedures presenting different degrees of complexity [1, 2] .
The main value of this scoring system is the scientific method used for its development [3] [4] [5] , together with its simplicity. Different validation studies carried out [6, 7] have found mortality overprediction, especially among patients with low surgical risk. In 1998, a new equation known as P-POSSUM was therefore created to more accurately predict surgical mortality.
This new system applies linear instead of exponential equations and uses different constants and values for the same Physiological and Operative Scores. Both POSSUM and P-POSSUM scores have proved to be reliable mortality predictors for patients undergoing general and special surgery [1, 4, 5, 8] . When applied specifically to colorectal surgery, these scoring systems have been found to overpredict mortality in elective surgical procedures and to underpredict mortality in elderly patients and in cases of emergency surgery [9] [10] [11] [12] . This fact led to the development, in 2004, of the CR-POSSUM, which is specific for colorectal surgery [13] . It seems to be the most accurate scoring system, compared with the previous ones [14] [15] [16] .
Our aim was to evaluate the quality of care at our centre, assessing morbidity and mortality over several years. Therefore, we applied the three described scoring systems to a group of patients consecutively diagnosed with rectal adenocarcinoma and treated with long term preoperative chemoradiotherapy and surgery. Furthermore, we wanted to determine the relationship with other factors that may predict complications.
Patients and methods
Between January 1995 and December 2004, 273 patients diagnosed with rectal adenocarcinoma (tumour margin within 16 cm from the anal verge) were treated in our hospital. A multidisciplinary team made up of oncologists, radiotherapists and surgeons with a special interest in colorectal pathology attended them. A database was created with prospective information collected about the patients (age, gender, BMI and ASA) [17] , the surgical procedures (type and duration of surgery, ileostomy, type of anastomosis and blood transfusion), the radiotherapy (dose, duration and interval between radiotherapy and surgery), and about the tumour (tumor, node, metastasis [TNM] staging [18] and location).
Patients were assigned to two different groups: group A was made up of 170 patients, who were given both chemoradiotherapy and surgery, and group B was made up of 103 patients treated with surgery alone. Chemoradiotherapy was prescribed for all patients whose preoperative staging revealed tumour infiltration deeper than the muscular layer (T3) or lymph nodes suspicious of metastasis (N+). All patients not fulfilling these criteria (71/ 103) as well as those with metastasis (M1) (24/103) were included in group B to avoid delay in systemic chemotherapy. Finally, patients who refused preoperative chemoradiotherapy were also assigned to group B (8/103).
Preoperative radiotherapy
External radiotherapy was applied in two, three and four fields according to the guidelines given in the 50th Report of the International Commission on Radiation Units and Measurements [19] , including the primary tumour and regional, mesorectal, presacral and internal iliac (up to L5-S1) lymph nodes. Most of the patients (77/103) received a standard dose of between 45 and 50.4 Gy in 25 fractions over 5 weeks, associated with chemotherapy based on 5-fluorouracil (FU) boluses during the first and last week of radiotherapy. Fifteen patients received a reduced dose due to treatment intolerance and eleven received a dose over 50.4 Gy. All of them underwent surgery between the fourth and sixth week after completing radiotherapy.
Surgical procedures
All the patients underwent intestinal preparation the day before surgery, as well as intestinal decontamination with oral antibiotic therapy, antithrombotic prophylaxis, gastric protection and intravenous antibiotic prophylaxis against anaerobes and gram negative bacteria. The procedures employed were as follows: anterior rectal resection with stapled anastomosis, abdominoperineal resection and Hartmann's procedure. A protective ileostomy was created according to the surgeon's decision, taking into account technical factors, the general health of the patient and the use of neoadjuvant therapy with chemoradiotherapy. In all cases, information was gathered prospectively about the duration of the surgical procedure, blood loss and intraoperative blood transfusion requirements as decided by the anaesthetists.
Statistical analysis
Data collection was carried out using a computer database, and was supervised by the same surgeon throughout the whole study. The physiological and surgery parameters of the POSSUM score previous to the year 2000 were obtained from such a database, while more recent param- 
Results

Series analysis
The demographic characteristics of the 273 patients are shown in Table 1 . The two groups are homogeneous for age, gender, BMI, ASA, type of surgery, need for blood transfusion, duration of surgery and hospital stay. Significant differences in tumour location and tumour stage between groups results from the type of therapeutic procedure, the main reason for the selection treatment (p= 0.002). Most of the patients allocated to preoperative radiotherapy (group A) received a standard dose of 45 to 50.4 Gy, with conventional fractioning (1.8 Gy), during a 5-week period. The mean dose was 4700 cGy (range 3,696-6,500 cGy). Chemotherapy with 5-FU (350 mg/m2/day) was given in the first and last week of the radiation period. The mean time between preoperative chemoradiotherapy and surgery was 38 days (range 30-61 days). The mean radiotherapy duration was 36 days (range 20-70).
The characteristics of the surgical procedures in both groups, with values of statistical significance, are also displayed in Table 1 . Thirty-five per cent of patients were admitted to the ICU after surgery according to criteria of the anaesthetists and depending on the behaviour of the patient in theatres. The mean time of surgery in group A was 170 min (range 70-540) and was 150 min (range 45-330) in group B, and there were no statistically significant differences. No statistically significant differences between the groups were found with regard to sphincter-preserving surgery (76.5% in group A vs 75.5% in group B) or blood transfusion (16.6% in group A vs 18.1% in group B). In group A, 38.3% of the patients underwent ileostomy vs 8.6% in group B (p<0.001). Other surgical procedures (cholecystectomy, hysterectomy, and hernia surgery) were combined with the tumour excision in 13% of the patients in group A vs 22.3% in group B (p=0.045).
Complications
The complications found in both groups are displayed in Table 2 . It is important to note that, although statistically significant differences were not found between both groups, the number of patients suffering from complications was smaller in group A (23%) than in group B (32%) probably due to the more advanced tumour stage in group B (Table 1) .
Global mortality in the series (30 days mortality) was found only in two patients (0.7%): one in each group. The patient (0.6%) in the group treated with radiotherapy died of severe myocardial ischemia during the early postoperative period and the patient (1%) in the group treated with surgery alone died of intra-abdominal haemorrhage.
The overall morbidity in our sample was 26.4% while that predicted by POSSUM was 31.2% (index observed/ predicted=0.84; Table 3 ). When analysing according to therapy groups, we found very good prediction for patients treated with surgery alone (group B) (O/P index=1.09), while for patients receiving neoadjuvant therapy (group A), POSSUM overpredicted the morbidity rate (O/P index= 0.71) ( Table 4) .
The results obtained for the surgical mortality rate and a comparison of them are displayed in Table 5 . Mortality prediction for POSSUM, P-POSSUM and CR-POSSUM Table 6 . When applied to different age groups, it accurately predicted the morbidity rate for middle-aged groups (51-60 and 61-70 years old). However, overprediction for the other groups (<51 and >70 years old) was found. The sample was segmented by anaesthetic risk (ASA I/II and ASA III/IV) and duration of surgery (<180 min and >180 min). We obtained an appropriate POSSUM prediction for those patients with ASA I/II (O/P index=0.99) and an overprediction for patients with ASA III/IV (O/P index=0.75). Concerning the duration of surgery, the prediction was appropriate for surgical procedures lasting more than 3 h (O/P index= 1.03), and morbidity was overpredicted in patients with a shorter duration of surgery (O/P index=0.68). Looking at the type of surgical procedure, we found an overprediction of the surgical complication rate for anterior rectal resection (O/P index=0.76) and for Hartmann's procedure (O/P index= 0.85), as well as an underprediction for abdomino-perineal resection (O/P index=1.15). Analysis by Dukes staging showed an appropriate prediction for patients with good prognosis; Dukes A and B (O/P index=1.04 and 0.98) and incorrect prediction for Dukes C and D (O/P index=0.73 and 1.29).
Finally, morbidity rates observed and expected through application of the POSSUM equation were compared for the different risk groups in our sample. For those groups with higher expected rates, the number of patients with complications observed was also higher. Analysing this fact we found a correct correlation between the proportion of patients with complications and the proportion of expected cases by POSSUM (Table 7) .
Discussion
Surgical results are classically measured in terms of morbidity and mortality rates and hospital stay [3] . However, it may be misleading to establish comparisons based only on these variables. We should take into account that not all cases present the same degree of complexity and that reference hospitals usually have a concentration of the most complex ones, therefore registering higher rates of morbidity and mortality, and hospital stay [20] . This issue has been widely described in the literature [3, [21] [22] [23] and that is why several scoring systems for prediction and quality care control have been developed over the years. The only way to objectively compare surgical teams, hospitals and surgeons is by estimating morbidity and mortality rates adjusted according to the risk of each patient or group of patients [3] .
In our study, we wanted to assess all these aspects, so as to fully comprehend our situation and to be able to analyse it as a part of the health system.
The principal investigator was present during the data collection process and supervised data input in the different models and scoring systems. Physiological and Operative Severity Scores were similar to series previously analysed, allowing us to compare them with the results of other institutions ( Table 8 ). The mean Physiological and Operative Severity Scores were 16.07 (range 12-35) and 13.03 (range 8-30), respectively. Predicted mean morbidity was 31.2% and predicted mean mortality was 6.64% with the POSSUM score. Observed morbidity was 26.4% and observed mortality was 0.7%. The number of emergency surgical procedures in our study was zero since the few patients who presented as emergencies were stabilized and later referred for elective surgery. This decrease in morbidity and mortality rates among emergency patients treated electively was described by Tekkis et al. where mortality rates were reduced from 20 to 12.9% in patients treated for obstructive colorectal cancer [13] .
It is well-known that POSSUM and P-POSSUM overpredict general mortality and morbidity, and that the creation of subgroups is needed to more accurately estimate risk values [9] [10] [11] [12] . CR-POSSUM is a specific scoring system for colorectal cancer and is more reliable but still needs further adjustment [15, 16] . In an attempt to improve the validity of POSSUM, we analysed the effect it has over different variables classically associated with surgical morbidity.
The classification of the American Society of Anesthesiology (ASA) has been used since 1961 to easily quantify surgical morbidity and mortality risk [24] . It has proven to be an accurate predictor of surgical risk, with an added predictive value when taking into account the age of the patients [25] . ASA staging, being a simple method, is partially open to subjective interpretation by the specialists and that is why it has been incorporated in other predictive indexes. In our analysis, we found an overprediction of the surgical morbidity rates for those patients with low anaesthetic risk (ASA I/II; 20.6% vs 27.3%) and a precise prediction for those with high anaesthetic risk (ASA III/IV; 40.5% vs 40.9%). In line with this, we also found an overprediction of the morbidity risk for the extreme age groups (<51 and >70 years old), and an accurate prediction for those age groups where colorectal cancer is more common (51-60 and 61-70 years old). Similar to other published studies [26] [27] [28] , we did not find a higher incidence of complications among elderly patients. Therefore, we consider that similar surgical procedures can be done without increasing the number of complications.
Traditionally, radiotherapy has been associated with higher postoperative morbidity and mortality rates, princi- pally due to a higher incidence of anastomotic leak. However, evidence for this is derived only from scientific experiments [29, 30] . According to our experience and that of other studies [31] [32] [33] [34] [35] , the morbidity rates are not increased in patients treated with neoadjuvant therapy (group A), compared to those patients treated with surgery alone (group B) (22.9% vs 26.4%). When applying POSSUM to the groups created with this variable, we observed an overprediction of morbidity rates in patients receiving neoadjuvant therapy (group A) (22.9% vs 32.05%) and an accurate prediction in patients treated with surgery alone (group B) (32% vs 29.1%). This disparity could be explained by the absence of this variable (neoadjuvant therapy) among the physiological and operative parameters considered in POSSUM. We believe it is important to incorporate this variable in future predictive models. The POSSUM scoring system includes in the Operative Severity Score the type of surgical procedure and the degree of tumour malignancy, classified from less to more (minor, intermediate, major and major+) and into lack of malignancy, primary neoplasia, lymph node metastasis and distant metastasis. Most of the surgical procedures were classified as major procedures. However, we analysed them according to the type of surgical procedure (anterior rectal resection, abdominoperineal resection and Hartmann's procedure) and the duration of surgery (<180 min and >180 min), noting an overprediction of the risk of complications for the anterior rectal resection and for Hartmann's procedure as well as an underprediction for the abdominoperineal resection. Similarly, when surgical time measured from the first incision up to the closure of the laparotomy was longer than 3 h, POSSUM correctly predicted the operative morbidity rate. It was, however, overpredicted for shorter surgical procedures. It is well known that abdominoperineal resection carries a higher incidence of operative complications, compared to anterior rectal resection [36, 37] . In our experience, we found a higher rate of wound infection and of abdominal abscess among patients undergoing rectal amputation, especially due to delayed perineal wound healing (5.0% vs 19.6%; p= 0.02) and (2.5% vs 8.9%; p=0.03). From these results, we consider it useful to define the domain "type of surgery" according to type of surgical procedure. Our results show a good correlation for low stages (Dukes A and B) and an underprediction for those cases with worse prognosis (Dukes C and D). The original POSSUM, as we saw above, categorises the domain "malignancy stage" according to the degree of malignancy; later modifications (CR-POSSUM) incorporate Dukes classification in the domain, probably correcting this potential error.
Finally, in an attempt to assess the internal consistency of POSSUM scoring system and guided by the work of Ramkumar [15] , we validated the precision of POSSUM, using stratified risk intervals (Table 7) . We have seen that when the expected proportion of complications in POS SUM increases, the number of patients with complications in our study increased also.
In conclusion, according to our experience, we think that the profit of these scores is to make results between institutions and publication comparable. POSSUM score should not be the only instrument to decide the best surgical option for patients according to our investigated results. The POSSUM scoring system and its later modifications (P-POSSUM and CR-POSSUM) overpredict the risk of operative mortality. In spite of that, POSSUM has permitted an important advance in the evaluation of colorectal cancer surgery, correctly estimating the probability of surgical morbidity in most cases. The described predictive models could also be used as a further step in the patient's preoperative informed consent. It could also be used to compare the clinical practice among several institutions and to detect and correct errors. So far, a precise scoring system for colorectal surgery has not been developed. However, successive modifications will bring it closer to reality. We consider that modifications in operative parameters according to the type of surgical procedure and specifications for neoadjuvant therapy, as well as modifications in physiological parameters including life style habits, could improve prediction of surgical risk in future. Further studies on these lines are needed to more accurately identify potential risk factors for surgical complications.
